Cellular Reprogramming's Incubator/Accelerator Round

Cellular Reprogramming raised a round of funding on January 14, 2014. Investors include JLabs.

Cellular Reprogramming provides rapid, low-cost, footprint-free, xeno-free derivation of induced pluripotent stem cells (iPSCs) from human fibroblasts on a fee-for-service basis.…

Articles about Cellular Reprogramming's Incubator/Accelerator Round: